Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04095091 · ClinicalTrials.gov registry record

Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)

A clinical trial, sponsored by University of Wisconsin, Madison.

Terminated
Registry status
30
Enrollment target

NCT04095091 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04095091 was terminated before completion, sponsored by University of Wisconsin, Madison.

TERMINATED
Registry status
30 participants
Enrollment target

Study Summary

The primary objective of this protocol is to evaluate the feasibility of acquiring simultaneous 4D ultrasound and 4D MRI scans. The imaging performance of the US and MRI scans will be characterized. The secondary objective of this study is to determine if several salient features identified in the US scan can be used to predict target motion identified in the MR scan.

Interventions

  • DEVICE 4D Planar US Transducer

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-09-14
Est. Completion 2019-10-04

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT04095091

The ClinicalTrials.gov registry entry for NCT04095091 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which 4D Planar US Transducer is the first listed.

NCT04095091 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04095091 about?

NCT04095091 is a clinical study titled "Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)". The primary objective of this protocol is to evaluate the feasibility of acquiring simultaneous 4D ultrasound and 4D MRI scans. The imaging performance of the US and MRI scans will be characterized. The secondary objective of this study is to determine if several salient features identified in the U...

What is the current status of trial NCT04095091?

This trial is currently terminated. The enrollment target is 30 participants. The study started on 2017-09-14. Estimated completion is 2019-10-04.

What interventions are being tested in trial NCT04095091?

The interventions under investigation include: 4D Planar US Transducer (DEVICE).

Who is sponsoring clinical trial NCT04095091?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.